Public, Private Sectors Should Address Antibiotic Resistance After Latest CDC Warning

Noting CDC Director Tom Frieden on Monday released a report showing “two million people in the United States are sickened every year with antibiotic-resistant infections, with at least 23,000 dying as a result,” a Washington Post editorial states, “The global toll is certainly much higher.” The editorial asks, “What is being done about that?” and continues, “Similar warnings have been issued for at least three decades, yet the public has largely shrugged.” In addition, “Big Pharma turned away from antibiotic development in recent years because of economic factors; put simply, drugs for chronic diseases offered higher returns,” the Washington Post writes. “There is a crying public need for more drug development in antibiotics. If the pharmaceutical industry can’t do it, more government involvement may be required,” the editorial states, outlining some steps already undertaken by government agencies. “Let’s hope we won’t look back on the latest CDC report as just another warning that was forgotten,” the editorial concludes (9/19).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.